Abstracts from current global literature: Human papillomavirus vaccine (original) (raw)
Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus
Robert Jacobson
Postgraduate Medicine, 2010
View PDFchevron_right
Human papilloma virus vaccination: Review article and an update
Zahra Maleki
View PDFchevron_right
Update on Safety and Efficacy of HPV Vaccines: Focus on Gardasil
International Journal of Molecular and Cellular Medicine
International Journal of Molecular and Cellular Medicine (IJMCM), 2021
View PDFchevron_right
Prevention of cervical cancer: journey to develop the first human papillomavirus virus-like particle vaccine and the next generation vaccine
Janine Bryan
Current Opinion in Chemical Biology, 2016
View PDFchevron_right
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices
Elizabeth Unger
MMWR. Morbidity and mortality weekly report, 2015
View PDFchevron_right
Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases
Rachel Skinner
Expert review of vaccines, 2016
View PDFchevron_right
Human Papillomavirus Vaccination: Expected Impacts and Unresolved Issues
Gary Freed
The Journal of Pediatrics, 2008
View PDFchevron_right
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
Sara Tous
Infectious Agents and Cancer, 2012
View PDFchevron_right
Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil??): Profile Report1
Asif Siddiqui
BioDrugs, 2006
View PDFchevron_right
Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008–2012
Martin Steinau
Emerging Infectious Diseases, 2015
View PDFchevron_right
Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: A pooled analysis of 11 clinical trials
Karin Hardt
Human Vaccines, 2009
View PDFchevron_right
Gardasil® - The New HPV Vaccine: The Right Product, the Right Time? A Commentary
Neil Arya
Healthcare policy = Politiques de santé, 2010
View PDFchevron_right
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Mona Saraiya
PsycEXTRA Dataset, 2000
View PDFchevron_right
HPV vaccines to prevent cervical cancer and genital warts: an update
Rita Verhelst
Vaccine, 2014
View PDFchevron_right
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial
Robert Kurman
Lancet (London, England), 2017
View PDFchevron_right
Efficacy and safety of human papillomavirus vaccine for primary prevention of cervical cancer: A review of evidence from phase III trials and national programs
Priyanka Singh
South Asian Journal of Cancer, 2013
View PDFchevron_right
Vaccines against human papillomavirus infections: protection against cancer, genital warts or both?
Ian Frazer
Clinical Microbiology and Infection, 2016
View PDFchevron_right
Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges
T. Slavik
Clinical Microbiology and Infection, 2012
View PDFchevron_right
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
Elmar Joura
New England Journal of Medicine, 2015
View PDFchevron_right
Human Papillomavirus Vaccine:Its Application and Perspective
Kazuhiro Takehara
View PDFchevron_right
Clinical Trials of Human Papillomavirus Vaccines
Jorma Paavonen
Elsevier eBooks, 2020
View PDFchevron_right
Preventing Cancer with Two Injections, A Clinical Review of the HPV Vaccination
jay shubrook
Osteopathic Family Physician, 2019
View PDFchevron_right
Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
Suzanne Garland, Cosette Wheeler
JNCI Journal of the National Cancer Institute, 2010
View PDFchevron_right